Pemberian Antijamur Empiris pada Keganasan dengan Demam Neutropenia
Sari
Risiko infeksi jamur meningkat pada pasien dengan neutropenia terutama anak dengan keganasan. Pemberian
antijamur empiris pada pasien dewasa sudah sering dilakukan dengan tujuan untuk menurunkan angka
morbiditas dan mortalitas terutama mereka dengan keganasan yang disertai demam berkepanjangan dan
neutropenia. Belum didapatkan metode diagnosis infeksi jamur sistemik pada keadaan tersebut, namun
pemberian antijamur dengan jelas memberikan keuntungan. Konsensus pemberian antijamur pada kasus
anak dengan keganasan belum ada, untuk itu perlu penelusuran bukti berbasis medik yang memadai sehingga
para praktisi onkologis anak dapat dengan benar memberikan antijamur empiris.
Kata Kunci
Teks Lengkap:
PDFReferensi
Aygun B. Supportive care and management of oncologic
emergencies. Dalam: Lanzkowsky P, penyunting. Manual
of Pediatric Hematology and Oncology. Edisi ke-4. San
Diego: Elsevier; 2005.h.695-748.
Windiastuti E. Antibiotik pada demam neutropenia.
Dalam: Tumbelaka AR, Trihono PP, Kurniati N, Widodo
DP, penyunting. Pendidikan Kedokteran Berkelanjutan
Ilmu Kesehatan Anak XLVII: Penanganan Demam pada
Anak Secara Profesional. Edisi ke-Jakarta: Departemen
Ilmu Kesehatan Anak FKUI-RSCM; 2005.h.42-50.
Mendes AVA, Sapolnik R, Mendoca N. New guidelines
for the clinical management of febrile neutropenia
and sepsis in pediatric oncology patients. J Pediatr
;83:54-63.
Blyth CC, Palasanthiran P, O’Brien TA. Antifungal
therapy in children with invasive fungal infection: a
systematic review. Pediatrics 2007;119:772-84.
Gotzsche PC, Johansen HK. Routine versus selective
antifungal administration for control of fungal infections
in patients with cancer. Cochrane Database of Systematic
Reviews 2009.
Immune deficiency. Dalam: Isaacs D, penyunting.
Evidence-based Pediatric Infectious Diseases. Edisi ke-1.
Massachusetts: Blackwell Publishing; 2007.h.117-25.
Oxford Centre of Evidence-based Medicine. Oxford
Centre for Evidence-based Medicine Levels of Evidence
(March 2009). Diunduh dari: http://www.cebm .net/index.
aspx?o=1025.
Sandler ESM, Mustafa MM, Tkaczewski IRN, Graham
ML, Morrison VA, Green M dkk. Use of amphotericin
B colloidal dispersion in children. J Pediatr Hematol
Oncol 2000;22:242-6.
Pizzo PA, Robichaud KJ, Gill FA, Witebsky FG. Empiric
antibiotic and antifungal therapy for cancer patients
with prolonged fever and granulocytopenia. Am J Med
;72:101-11.
EORTC International Antimicrobial Therapy
Cooperative Group. Empiric antifungal therapy in febrile
granulocytopenic patients. Am J Med 1989;86:672.
Wingard JR, Vaughn WP, Braine HG, Merz WG, Saral
R. Prevention of fungal sepsis in patients with prolonged
neutropenia: a randomized, double-blind, placebocontrolled
trial of intravenous miconazole. Am J Med
;83:1103-10.
Goldberg E, Gafter-Gvili G, Robenshtok E, Leibovici L,
Paul M. Empirical antifungal therapy for patients with
neutropenia and persistent fever: systematic review and
meta-analysis. Eur J Cancer 2008;44:2192-203.
Blyth CC, Hale K, Palasanthiran P, O’Brien T, Bennett
MH. Antifungal therapy in infants and children with
proven, probable or suspected invasive fungal infections.
Cochrane Database of Systematic Review 2010.
Marchetti O, Cordonnier C, Calandra T. Empirical
antifungal therapy in neutropaenic cancer patients with
persistent fever. Eur J Cancer Supp 2007;5:32-42.
Alexander SW, Pizzo PA. Special consideration in
children with fever and neutropenia. Dalam: Rolston K,
Rubenstein EB, penyunting. Febrile Neutropenia. Edisi
ke-1. London: Martin Dunitz Ltd; 2001.h.201-14.
Meckler G, Lindemulder S. Fever and neutropenia in
pediatric patients with cancer. Emerg Med Clin North
Am 2009;27:525-44.
Villarroel M, Aviles CL, Silva P, Guzman AM, Poggi H,
Alvarez AM dkk. Risk factors associated with invasive
fungal disease in children with cancer and febrile
neutropenia: a prospective multicenter evaluation.
Pediatr Infect Dis J 2010;29:816-21.
Klastersky J, Paesmans M. Antifungal therapy in febrile
neutropenic patients: review of treatment choices and
strategies for aspergillar infection. Support Care Cancer
;15:137-41.
Zaoutis TE, Benjamin DK, Steinbach WJ. Antifungal
treatment in pediatric patients. Drug Resistance Updates
;8:235-45.
Johansen HK, Gotzsche PC. Amphotericin B versus
fluconazole for controlling fungal infection in neutropenic
cancer patients. Cochrane Database of Systematic
Review 2002.
Link H, Bohme A, Cornely OA, Hoffken K, Kellner O,
Kern WV dkk. Antimicrobial therapy of unexplained
fever in neutropenic patients. Ann Hematol 2003;82
(Suppl 2):S105-17.
DOI: http://dx.doi.org/10.14238/sp12.3.2010.211-6
Refbacks
- Saat ini tidak ada refbacks.
##submission.copyrightStatement##
##submission.license.cc.by-nc-sa4.footer##
Email: editorial [at] saripediatri.org
Sari Pediatri diterbitkan oleh Badan Penerbit Ikatan Dokter Anak Indonesia
Ciptaan disebarluaskan di bawah Lisensi Creative Commons Atribusi-NonKomersial-BerbagiSerupa 4.0 Internasional.